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An Audit of Supplementary Prescribing within South 
West Yorkshire Mental Health Trust 
 
Richard Clibbens, Hazel Baxter, Stephen Hemingway 
 
Abstract 
 
Results are presented from an audit of mental health nurses (MHNs) who 
have undertaken training in order to practise as supplementary prescribers 
as part of an evaluation of the development of non-medical prescribing 
(NMP) across South West Yorkshire Mental Health Trust (SWYMHT). 
Quantitative (demographics) and qualitative (open-ended statements) 
results derived from a questionnaire survey are analysed and compared to 
the national picture. Implications for the  governance arrangements which 
need to be in place for the further development of non-medical prescribing 
in mental health care, both for the Trust and nationally, are suggested. 
 
Key words: Non medical prescribing; Governance; Mental Health 
Nursing; Audit. 
 
Introduction 
 
After a slow start at the end of the last century, developments in nurse 
prescribing in the United Kingdom (UK) have moved swiftly over recent 
years (for a history of NMP see Mills 2008). There are now over 600 out of 
approximately 10,000 Mental Health Nurses (MHNs), who have been 
trained as independent and supplementary prescribers (Brimblecombe, 
2007). Having undertaken a 27 day theoretical, University, minimum degree 
level course, as well as 12 days of medical mentoring (NPC et al 2005) 
these MHNs can potentially prescribe any drug from the British National 
Formulary (BNF). In mental health, national guidance regarding the 
implementation of MHN prescribing has signalled Government support for 
these developments (NPC et al 2005). The Chief Nursing Officer’s review 
of mental health nursing also identified the importance of this developing 
role for MHN’s in making a difference within services (Department of Health 
2006, 2007). There is now some published evidence describing the 
development of prescribing by MHNs (Grant, et al 2006, Jones & Jones, 
2007; Hemingway & Harris, 2006; Wix, 2007; Norman et al 2007). However 
despite this national emphasis and a growing evidence base for the 
benefits of MHN prescribing, the national picture is one of seemingly 
piecemeal and patchy implementation with significant numbers of trained 
MNH prescribers in some areas of the country and very few in others (NPC 
et al 2005). 
 
Despite the evidence that prescribing by MHNs is developing across a wide 
range of mental health specialties, and the positive news that MHN 
prescribing has been evaluated safely (Norman et al, 2007), the reality 
remains its implementation by mental health trusts has been sporadic 
(Bradley et al., 2008). In 2004, four trusts had 81% of the MHN prescribers 
who had completed their training (NPC et al 2005: Murray, 2007).  This 
does not reflect the UK as a whole where the planning and implementation 
of MHN prescribing has appeared more opportunistic and haphazard 
(Mazhindu & Brownshill, 2003; NPC et al 2005). MHNs have potentially 
been trained to prescribe without governance procedures in place for them 
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to practice, or a clear strategy to support the implementation of their new 
role, with one study sample showing that only 51% of MHNs trained were 
actually practicing as prescribers (Grey et al., 2005). In comparison to 
general adult nursing practice, where nurse prescribing is often well 
established, prescribing implementation by mental health trusts appears to 
be far more cautious and thus the roll out of nurse prescribing appears to 
be slow (NPC et al., 2005: DH, Bradley et al 2008).  This is despite the 
proposal by both the England and Scotland reviews of mental health 
nursing that non medical prescribing is central to MHN’s improving their 
contribution to service user recovery (Department of Health, 2007; 
Snowden 2007): 
 
Indeed Recommendation 13 of Values to Action stated: 
 
‘Service providers are to put in place arrangements to support 
the implementation of nurse prescribing, based on local need, 
taking into account the potential for service redesign and skill 
mix review, using both supplementary and independent using 
both supplementary and independent prescribing 
arrangements” (Department of Health 2007)’. 
 
Set against the national picture where there are clear policy directives to 
support MHN prescribing, it was decided to conduct an audit of current non-
medical prescribing activity across SWYMHT. The audit was co-ordinated 
by the Trust NMP steering group which commissioned the Trust’s clinical 
governance and support team to evaluate the impact of non medical 
prescribing to date across the Trust. The Trust implemented a framework 
for non medical prescribing in May 2005, which identified the governance 
and procedures for staff undertaking supplementary non medical 
prescribing. This detailed framework includes: a pathway for the 
identification and approval of staff undertaking non medical prescriber 
training, the process of induction for newly qualified non medical 
prescribers and the continued professional development (CPD) strategy for 
clinicians undertaking this area of practice. The first stage of this audit was 
completed in late 2007 and provided an indication as to the effectiveness of 
the Trust governance arrangements for NMP. 
 
Background 
 
The Trust introduced supplementary prescribing in June 2005. The 
Department of Health (2004b) defines supplementary prescribing as  
 
“A voluntary partnership between an Independent Prescriber 
(a doctor or dentist) and a Supplementary Prescriber to 
implement an agreed patient specific Clinical Management 
Plan (CMP) with the Patient’s agreement.” . 
 
Supplementary prescribing, with the agreement of service users, enables 
nurses, pharmacists and allied health professionals to prescribe and make 
adjustments to medication based on agreed clinical management plans. 
This facilitates a more flexible approach to care delivery and the 
development of professional roles.  
 
Supplementary prescribing is underpinned by the following key principles: 
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• That the service user is treated as a partner in their care and is involved 
at all stages in decision making, including whether part of their care is 
delivered via supplementary prescribing. 
 
• The importance of communication between the prescribing partners. 
 
• The need to access shared service user records. 
 
Aim and Objectives 
 
The stated aim of the overall audit project was to evaluate the impact of 
NMP in the Trust with the following objectives: 
 
• To ascertain prescribing activity and views of the qualified NMP. 
 
• To audit the clinical management plans (CMP). 
 
• To ascertain service users and carers views of their experience of the 
NMP service. 
 
This paper presents the results of the first stage of the audit in identifying 
current prescribing activity and eliciting the views of qualified non medical 
prescribers employed within the Trust. 
 
Methodology 
 
An audit steering group was established with members from the Trust’s 
NMP steering group and clinical governance and support team (CGST) The 
Chief Pharmacist provided a list of the current qualified NMPs, from a 
database maintained on behalf of the NMP steering group.  
 
Survey Questionnaire 
 
A 24-item survey questionnaire was developed. The survey consisted of 
open and closed questions focussing on demographic details of the 
respondent NMPs (3 items) as well as specific questions designed to elicit 
if they are actively prescribing and how many times per week (4 items). 
Also, examples of CPD activities were requested (2 items). The 
experiences and views of respondents since qualifying as a prescriber and 
how this has impacted on clinical practice in terms of their role and 
outcome for the service user were also sought. In addition, an open ended 
part of these questions invited respondents to describe examples of their 
experiences since undertaking the course (14 items). Finally one item 
contained a section to describe any further comments. 
 
The Clinical Governance Support Team e-mailed the survey to all 
prescribers for return either electronically or as a hard copy. The surveys 
were anonymised. A repeat electronic questionnaire was sent as a 
reminder and followed up by a posted hard copy, to maximise opportunity 
for qualified Trust non medical prescribers to respond. 
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Results 
 
Response Rate and Demography 
 
A total of fifteen questionnaires were emailed to the non-medical 
prescribers (NMP) of which nine (60%) were completed and returned to the 
CGST. 
 
Respondents were asked if they were currently prescribing of which three 
(33%) stated they were, with six not prescribing at the time of audit. It was 
not clear why there had been such a small return from the pool of practising 
MHN prescribers within the Trust. In looking at the small number who 
actually were prescribing  this is not unusual. Evidence from a UK study 
has shown that only 51% of MHNs who had undertaken the appropriate 
training had begun prescribing up to one year post qualification (Gray et al 
2005). Secondly a study from the US reported that 18 months following 
completion of appropriate training only 40% of MHN’s were practising as 
prescribers (Kaas et al 1998).  
 
Respondent Characteristics 
 
The three prescribing MHNs had all been qualified nurses for over 15 
years, these respondents were working in either adult mental health or 
older people’s mental health teams (OPMH). One had been qualified as a 
NMP for less than a year, one for 1-2 years and one for 2-3 years. Of the 
six MHNs (67%) not currently prescribing five had been qualified nurses for 
over 15 years and one for 6-10 years. Hemingway (2005) and Hemingway 
and Harris (2006) found experience to be a key factor as to whether MHNs 
developed toward prescribing. 
 
Reasons for not Prescribing 
 
Five respondents gave the following reasons for not prescribing.   A key 
reason stated was for the necessary structures to be in place to enable 
them to prescribe: 
 
“Awaiting registration to be processed from NMC.”  
 
“Awaiting medics to commence with the team.  Once this is in place 
will be looking into implementing with immediate effect.” 
 
“Need for cross boundary agreement with (acute) Trust.” 
 
Whilst another reply showed a more concerning aspect: 
 
“Since qualifying no support, feels like left to fend for self.  
Tried to get going - still waiting for contact, having asked for 
help.” 
 
An absence of need within the service structure was also identified as a 
barrier by one respondent: 
 
“Following new ways of working there are usually doctors 
available to prescribe.” 
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Bailey and Hemingway (2006) highlight inter and intra professional 
variables that affect the MHNs development toward prescribing. Clearly in 
this example, professional variables are seen by the respondent as a key 
factor that has prevented them from prescribing. Bradley et al (2008) 
particularly draw attention to the need to appropriately plan how the new 
MHN prescriber will develop their role within service configurations.  
 
Frequency of Prescribing 
 
One NMP prescribed 1-3 times per week and issues an average of 12 
prescriptions per month, and one prescribed less than once per week and 
issued an average of two prescriptions per month. The third prescribed less 
frequently due to a reported “influx of doctors has created a challenge.” 
During the early stages of developing this role following qualification, 
prescribing in a limited fashion has been described as an ideal way for the 
MHN to gain confidence in undertaking prescribing activity before 
developing competently with a wider prescribing portfolio (Bailey 1999, 
NPC et al 2005). As NMP becomes more prevalent in the Trusts future 
business and service development plans it will be of interest to audit the 
type and scope of prescribing activity to map how this has developed. 
Continuous Professional Development (CPD) 
 
CPD is a very topical issue for the development of nurses as prescribers. 
Criticism has been levelled toward nurses’ for having an insufficient 
knowledge of pharmacology and medicines management in relation to 
prescribing (Avery and Pringle 2005, Cressey 2007). Alongside this there 
have been questions as to whether the generic prescribing course 
curriculum adequately prepares the MHN for prescribing practice (Bailey 
and Hemingway 2006, Bradley et al 2008). Therefore CPD activity is an 
important issue for MHN’s in developing and sustaining competence as 
prescribers. 
 
Results from the two CPD response questions showed respondents were 
satisfied with the CPD updates they had received in the last year (very 
satisfied = 2, satisfied = 7).  
 
Respondents were asked to indicate which CPD activities they had 
accessed. All nine NMPs had attended education events organised by a 
regional good practice network for non medical prescribing and medication 
management in mental health (M62 Network), and six had attended a Trust 
Medicines Management Update. Two had completed a local University 
Medicines Management and Psychiatry Module. One had attended 
pharmaceutical company drug representative updates and one described 
the use of internal networking for CPD.  
 
Comments displayed agreement with the need for CPD activity: 
 
“Safe ideas, experiences, keep up to date.” 
 
“As this is a period of development and change and not 
always consistent approach in every trust it is important to 
have information on a regular basis.”  
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About the difficulty of attending CPD: 
 
“Often hard to attend due to time constraints and 
mandatory/NMC training CPD.” 
 
And with one appearing to questioning the usefulness of available CPD: 
 
“Lot of meetings feel like lip service.” 
 
CPD Opportunities 
 
Respondents were asked if there were any other CPD updates that would 
be beneficial to them. 
 
“Would like to tie into the journal clubs used by the medical 
staff.” 
 
Some respondents identified a need for more formal education: 
 
“Psychopharmacology modules.” 
 
 “Psychiatric medication.” 
 
One seemed satisfied with the present arrangements, perhaps reflecting on 
the pressure on time to undertake such activity: 
 
“I think there are sufficient events currently.” 
 
Impact of NMP Training 
 
The NMP course is designed to facilitate existing experiential knowledge of 
medicines toward the student being able to prescribe competently within 
their own scope of practice. This is supplemented in the clinical supervision 
sessions with the medical mentor. The student then prepares for practice 
(Bailey and Hemingway 2006). 
 
Respondents were asked whether developing as a prescriber has had an 
impact on their knowledge of medicines and their interactions. 
 
Six respondents said that prescribing activity has increased their 
knowledge of medicines (current prescribers = 2, not currently prescribing = 
4), and one prescriber said it had not increased their knowledge. Two did 
not answer the question.  
 
Two currently prescribing commented. Firstly on their use of information 
resources: 
 
   “Always use BNF and Maudsley prescribing guidelines.” 
 
And, how the course facilitated their development in this aspect of 
prescribing: 
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“In becoming qualified to prescribe I became more aware and 
informed of the broader picture of prescribing and my 
accountabilities.” 
 
Four currently not prescribing commented, indicating that they anticipate 
development with regard their knowledge of medicines: 
 
“I’m sure it will when I commence prescribing.” 
 
How the course has facilitated their knowledge: 
 
“Now more aware of side effects and how medication interacts 
with the body.” 
 
One described how they stayed motivated: 
 
“Despite not prescribing have kept interest.” 
 
And the need to keep updated: 
 
“Have not prescribed but being a prescriber requires regular 
self directed update re BNF and research articles.” 
 
Adverse Drug Reactions 
 
Intolerable side effects are a major reason why the service user 
discontinues taking psychotropic medication with a subsequent high 
chance of relapse (NPC et al (2005). Therefore, if the NMP is to have an 
impact this is one of the outcomes that would need addressing. Six 
respondents reported that developing toward prescribing practice had 
increased their knowledge of adverse drug reactions (current prescribers = 
2, not currently prescribing = 4), and one prescriber said it hadn’t increased 
knowledge. Two did not answer the question. 
 
Two currently prescribing commented. One described how they seek to be 
competent in this area as well as the service as a whole. 
 
“Yes, discuss with Dr X, psychiatrist and research if unsure 
about adverse reactions.  Carried out training for other staff.” 
 
With the reminder that developing as a prescriber brings responsibilities: 
 
“Again I need to be aware of adverse drug reactions due to my 
accountability.” 
 
Two not currently prescribing commented that actively prescribing will 
highlight the need to be able to assess and take appropriate treatment 
strategies: 
 
“I’m sure it will when I commence prescribing.” 
 
“More alert to possible side effects and how to report.” 
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Autonomous Practice 
 
Prescribing has been described as an advanced practice activity (Bailey 
and Hemingway 2006). To be an effective prescriber and to be able to take 
decisions as necessary, the nurse needs to be able to work autonomously 
(NPC et al 2005). 
  
The three current prescribers said that prescribing had increased their level 
of autonomous practice, and two made the following comments. 
 
That prescribing needs to be seen within a systems approach: 
 
“It will do, but it also makes you aware of the need to act as a 
team to ensure all prescribers are aware of your 
prescriptions.” 
 
One respondent’s prescribing practice seemingly had not developed 
particularly autonomously. 
 
“Mainly repeat prescriptions.” 
 
Of the six currently not prescribing two reported it had increased their 
autonomous practice and one gave an example of how it has empowered 
their practice: 
 
 “Confidence in giving advice to acute hospital staff.” 
 
Workload Issues 
 
Before the MHN attends the prescribing course, planning and 
establishment of how this will impact on their role should be part of the 
governance in place (NPC et al 2005, Bradley et al 2008). Failure to do so 
negates the expensive process of training the MHN as an NMP and leads 
to a lack of confidence and motivation for the MHN who has invested so 
much into this new role. However four respondents said that NMP has an 
impact on their workload and positively made the following comments: 
 
That it has and will lead to practice more focussed toward prescribing: 
 
“Yes, tend to accept cases that are suitable for non medical 
prescribing.” (current prescriber) 
 
“I anticipate it will do.  I will be cross-working with more 
patients whilst maintaining my caseload.” (current prescriber) 
 
And that they feel that their practice will change: 
 
“Due to training yes but unsure until start prescribing.” (not 
currently prescribing) 
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Impact of NMP for Service Users 
 
The whole purpose of the development of non medical prescribing is to 
improve the prescribing service outcomes available for the service use and 
to make this service more accessible at the time of need (NPC et al 2005). 
The respondents were asked their views about the impact of NMP on their 
ability to improve their medicines management interventions for service 
users, and the responses are presented in the following four categories 
 
1.  Medicines Management 
 
Five felt that NMP had increased their skills in effective medicines 
management with service users. Three made the following positive 
comments. 
 
“Yes as I try to involve service users and give relevant easy to 
understand information and promote concordance.” (current 
prescriber) 
 
“I am now more aware of the wider range of experiences that 
influence a patients’ behaviour in taking, or not taking 
medication.” (current prescriber) 
 
“I pay more attention to medicine management than I did prior 
to the course.” (not currently prescribing) 
 
2.  Improvement in Care Provision? 
 
When asked if prescribing activities had positively improved the care they 
provide for service users, seven respondents reported that it had. When 
asked to give examples five made the following comments: 
 
“Again, I anticipate it will.  This is particularly with regard to out 
of hours access to medication and Trust in what is being 
prescribed.” (current prescriber) 
 
“Earlier access to medicines.” (current prescriber) 
 
“Yes, able to provide prescriptions and provide or adjust 
medication sooner.” (current prescriber) 
 
 “Can give an up to date knowledge of psychiatric medication 
to acute hospital patients.” (not currently prescribing) 
 
“I think I provide a more rounded service than previously.” (not 
currently prescribing) 
 
“It would if I were prescribing.” (not currently prescribing) 
 
3.  Service User Choice 
 
Seven respondents identified that NMP improves service user choice. Four 
made the following comments. 
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That it can have an immediate positive impact: 
 
“Yes as able to spend more time with service users and carers 
and adjust medication to suit their lifestyle, and to monitor side 
effects and adjust quicker.” (current prescriber) 
 
And that MHNs not yet practising as prescribers can see positive benefits in 
the change in service: 
 
“Not had direct feedback as not currently prescribing but I 
think some service users feel more able to negotiate with the 
person who regularly see's them” (not currently prescribing)”. 
 
“I am able to describe alternative medication and treatments to 
service users.” (not currently prescribing)”. 
 
“It is easier for clients to make an informed choice when 
medical treatment is part of a care plan which is 
comprehensive e.g. includes education re illness and not seen 
as something that happens in isolation at out-patient 
appointments.” (not currently prescribing)”. 
 
4.  Access to Medications  
 
Five respondents thought that medicines access is easier for service users 
where NMP is in place. Five made the following comments. 
 
As part of the changed service involving MHNs as prescribers: 
 
“Yes as often they will not attend out patient clinic or GP 
surgery.” (current prescriber)”. 
 
“Access is improved not only in ease of access, but also in the 
patient actually initiating access and requesting help by 
speaking more openly to a trusted worker rather than an 
unknown GP out-of-hours.” (current prescriber)”. 
 
That it will improve the service that can be provided: 
 
 “Offers a more flexible approach as team operate out of 
hours.” (not currently prescribing)”. 
 
But that only being able to practice as a supplementary prescriber will be 
restrictive on the MHN being able to make easier access to medicines 
achievable for service users: 
 
“Not in my case as I am not currently prescribing.  
Independent prescribing would make access to medication 
easier for service users.” (not currently prescribing)”. 
 
Yes if CMP but still has limits as independent prescribing would 
certainly provide easier access.”  (not currently prescribing)”. 
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Prescribers Views of NMP 
 
Respondents were asked how confident did they feel as a nurse prescriber, 
of which all three current prescribers felt quite confident. When asked to 
further explain their confidence one respondent commented : 
 
 “Quite confident but will be prescribing from a limited range 
until my confidence increases.” 
 
Of the six not currently prescribing, three felt quite confident and made the 
following realistic comments. 
 
“Due to not prescribing I am a little wary but I am aware of the 
theory and where to look and have supportive colleagues and 
will only prescribe if confident.” 
 
“Having not prescribed in the time since registration I would 
need to revise procedures to feel very confident.” 
 
Two reported not feeling very confident and one not at all confident due to 
not prescribing. These comments echo Kaas et al’s (2004) findings that the 
longer the time it takes for the nurse to start prescribing the more marked 
effect: 
 
“Due to not prescribing, but may feel worse if I do prescribe.” 
 
“This is because I am not actually prescribing.” 
 
“All confidence gone.” 
 
Positive Aspects of NMP 
 
Respondents were asked what they thought were the most positive aspects 
of NMP. Most reasons given were around speedier access to medication 
and benefits to the service user. The answers shown in these respondent’s 
views can be seen to fit well with national guidance describing the potential 
improvement in service provision available and better use of nurse’s skill 
and knowledge through the implementation of NMP (NPC et al  2005). 
 
“Earlier access to medication. “ (current prescriber). 
 
“Able to respond quicker to individuals needs.  Good working 
relationship with independent prescriber.” (current prescriber). 
 
“Timely access to medications for the service user and the 
time saved for the nurse who previously had to chase a 
doctor, potentially for several hours if working out of hours.” 
(current prescriber). 
 
“Benefits to clients and staff being a resource for information 
and actual prescribing and can prove helpful to some clients 
not to see a number of different professionals in a short space 
of time.” (not currently prescribing). 
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“More flexibility for service user, more choice as to who the 
service user wants to discuss such issues with.  Can be 
addressed quicker and prescription issued quicker.” (not 
currently prescribing). 
 
“Within my line of work…. it is often easier for the CPN nurse 
prescriber to introduce medication as a therapeutic 
relationship develops - rather than taking them all to out 
patients appointments at a psychiatric unit - which can still be 
a frightening place for both young clients and parents.” (not 
currently prescribing) . 
 
Two said that NMP had increased their knowledge and confidence. 
 
“Increase in knowledge, skills and confidence.” (not currently 
prescribing). 
 
“Increased knowledge and pharmacology and safe medicine 
management.” (not currently prescribing). 
 
Negative Aspects 
 
With any change in service provision (intrapersonal), and practice 
(interpersonal) there are potential pitfalls and barriers to overcome 
particularly when it involves the prescribing of medicines (Bradley et al 
2008). 
 
Respondents gave a number of intra and interpersonal aspects they felt 
were negative: 
 
“Risk of litigation.” (current prescriber). 
 
“Getting access to medical records.” (current prescriber). 
 
“Actually negotiating the opportunity to prescribe when 
working in an area where there are several doctors practicing.” 
(current prescriber). 
 
“Only able to be a supplementary prescribing in this Trust.” 
(not currently prescribing). 
 
“Have to have CMP that tries to cover the majority of 
medications you think you might need to prescribe.” (not 
currently prescribing). 
 
 “Political issues re funding medication.  E.g. Mental Health 
Trusts or PCTs in my area of work this could be either - but I 
have been told to be careful not to run up increase in PCT 
budget.” (not currently prescribing). 
 
“Lack of confidence in myself.” (not currently prescribing). 
 
“Poor support.” (not currently prescribing). 
 
“That I am not actually prescribing.” (not currently prescribing). 
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Four respondents made the following general comments. 
 
That they were restricted by the current Trust NMP framework which 
currently only supports supplementary practice: 
 
“I feel that Independent Nurse Prescribing would best suit my 
working practice.” (current prescriber)”. 
 
“Supplementary prescribing does not particularly fit with the 
service for which I work.  Perhaps independent prescribing 
would lead to improvements for service users.” (not currently 
prescribing). 
 
“I do find it difficult to be proactive in pushing forward nurse 
prescribing within my area because I am so busy. The 
preparation of GPs and consultant psychiatrists is a time 
consuming business as are clinical management plans.  I 
realise these are early days - but independent non-medical 
prescribing is a positive step in the right direction.” (not 
currently prescribing). 
 
And that that remuneration issues may be one barrier for the MHN to adopt 
prescriptive authority: 
 
“Should non medical prescribing offer financial rewards in 
terms of salary band?” (not currently prescribing). 
 
Conclusions 
 
Of the respondents for this audit, the majority were not yet prescribing. It 
was not clear why only a minority of practising non medical prescribers 
within the Trust had responded, while a greater proportion of those not yet 
prescribing had replied. This group were generally able to identify a range 
of benefits for their own development and practice from having completed 
their prescriber training and additionally identified that opportunities for 
CPD were mostly useful and adequate. The need for non medical 
prescribers in mental health to have a robust understanding of psychotropic 
medication has been identified as essential. This enables confident shared 
working with service users to enable effective choice in shared treatment 
decisions (Robson & Gray 2007). The group were able to identify a range 
of benefits for service users including improved and faster access to 
medication and the potential for the non medical prescriber to offer 
improved choice from a range of interventions including the prescribing of 
medication. These responses mirror the identified benefits of non medical 
prescribing in national policy documents (Department of Health 2004b, 
NPC et al  2005, DH 2006a & 2006b). 
 
The audit has highlighted the concerns of a number of respondents that 
their confidence in prescribing practice is or may be diminished by delay in 
the opportunity to actually prescribe following qualification. Some 
respondents additionally identified that independent NMP (rather than 
supplementary) may be more feasible, useful and appropriate for their 
areas of practice. The audit identified barriers to the implementation of 
supplementary prescribing in practice which included issues of time, 
presence of other (medical) prescribers within teams, reduced confidence, 
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fear of litigation, budgetary concerns and the lack of established cross 
boundary agreements between health care organisations. Hemingway 
(2005) and Bradley et al (2008) have identified the need for key 
organisational and support structures to be in place within mental health 
organisations to facilitate the effective and confident implementation of non 
medical prescribing. There is a clear need for MHN to receive adequate 
ongoing support in effectively implementing this new practice role within 
services (Murray 2007). Jones et al (2007) have previously identified that a 
lack of experience, shortfalls in supervisory arrangements and inadequate 
service redesign are all clear potential barriers to the effective 
implementation of non medical prescribing in mental health. For the Trust to 
successfully roll out non-medical prescribing it will be necessary to make 
the macro governance structures in place fit the micro context of clinical 
reality.  
 
Actions Arising from the First Stage of the Trust Audit 
 
The Trust non medical prescribing steering group is currently reviewing the 
results of this initial stage of the audit, with a particular focus on barriers to 
existing non medical prescribers in moving on to prescribing practice. Of 
the 15 MHNs who had completed prescriber training at the time of the 
audit, 10 (75%) are now practising as prescribers. The existing Trust NMP 
framework aims to set out clear processes for supporting prospective 
prescribers by ensuring managerial and service support is in place, 
including; access to appropriate prescribing budgets, independent medical 
prescribers and opportunities to utilise the qualification in practice. Formal 
requirements for attendance at CPD events are in place and CPD activity is 
audited and recorded annually for each non medical prescriber. The 
adequacy of these arrangements will now require review in light of the 
barriers and concerns raised by respondents. There is a clear need for 
ongoing work in ensuring that models of service re-design and business 
planning clearly include the development of NMP roles, to ensure this area 
of practice is clearly commissioned and forms a core element of provided 
mental health services. 
 
The second stage of the audit is now planned to review completed and 
anonymised CMPs from practicing non medical prescribers in the Trust, to 
identify compliance with legal and policy requirements for the CMP. The 
third and potentially most informative stage of the audit will comprise of a 
service user evaluation of non medical prescribing. 
 
The steering group are hopeful that the current planned development and 
implementation of Independent Prescribing within the Trust will additionally 
create greater choice of appropriate non medical prescribing mechanisms 
for Trust NMPs. 
 
Limitations 
 
Due to the small number of respondents in this local audit, the results 
presented in this article cannot be claimed in any way to be generalisable. 
The use of a survey questionnaire format limits the scope for a more in 
depth evaluation of non medical prescribing activity across the trust, such 
as could be provided by individual interviews.  Despite these evident 
limitations, the results of the audit do in many ways appear to reflect the 
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reported national experiences of MHNs undertaking prescribing and have 
enabled a critical evaluation of how the Trust can improve the necessary 
development plans and governance arrangements to facilitate the effective 
further development on mental health nurse prescribing. 
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